Twenty-one (32%) from the newborn infants of unaffected mothers tested positive for IAA in cord blood (Fig

Twenty-one (32%) from the newborn infants of unaffected mothers tested positive for IAA in cord blood (Fig. mothers. Since immune complexes are precipitated with protein A specific for IgG in the microassay and with polyethylene glycol Eliglustat lacking specificity for immunoglobulins in the conventional assay, our data indicate that insulin antibody levels decrease on average during pregnancy and that the increasing non-IgG anti-insulin activity observed in the conventional assay is induced by pregnancy and is present in both the maternal and the foetal circulation. Keywords:insulin antibodies, insulin autoantibodies, newborn infant, pregnancy, radiobinding assay, type 1 diabetes mellitus == Introduction == Antibodies to insulin frequently occur in patients exposed to exogenous insulin treatment [1]. A humoral immune response to endogenous insulin was found to be a marker of the preclinical phase of type 1 diabetes, when patients with newly diagnosed type 1 diabetes were reported to have detectable insulin antibodies (IA) before treatment with exogenous insulin [2]. Since then insulin autoantibodies (IAA) have been successfully used as predictive markers of future type 1 diabetes together with other islet autoantibodies [3,4]. The expression of insulin mainly in cells, the frequent appearance of IAA as the first autoantibody specificity detected in the preclinical period and the presence of IAA at high levels particularly in young children at the diagnosis of type 1 diabetes are all features that emphasize the role of insulin as a crucial antigen in the development of -cell destruction [5,6]. There are only a few reports of follow-up data on IA during diabetic pregnancy. Controversially, some studies have reported stable IA titres during pregnancy [7,8], while a slight decrease in IA levels has been documented in others [9,10]. No detailed data are available on IAA levels in nondiabetic women during pregnancy. IA detected in the cord blood of offspring of mothers with type 1 Tfpi diabetes are transplacentally transferred from the maternal circulation to the foetal circulation during pregnancy [7,8,1113]. All sensitive assays for the detection of IA are based on RIAs [14]. They require relatively large serum volumes to achieve high sensitivity, and mainly use polyethylene glycol (PEG) precipitation to separate antibody-bound insulin from free insulin. Williamset al.[15] have recently described a new radiobinding microassay which works with a smaller serum volume and uses protein A specific for IgG instead of PEG to precipitate the insulin-insulin antibody complexes. Increased anti-insulin activity has been reported in cord blood serum [12,16], and it has been suggested that this may be non-IgG-mediated, since it was not bound by protein A [16]. So far there are no data on whether this non-Ig anti-insulin activity is present only in cord blood or whether it is also found in the maternal circulation at delivery. We analysed IA in a population of 104 mother-infant pairs by the conventional assay as originally described by Palmeret al.[2] and by the new microassay in order to compare the concordance between the two and to investigate whether pregnancy affects the levels of IA. == Subjects and methods == == Subjects == The population comprised 104 mothers and their newborn infants from families with at Eliglustat least one family member (mother, father and/or sibling) affected by type 1 diabetes. The mother-infant pairs were initially recruited for the second pilot phase of an intervention trial which aims at evaluating the possible effect of elimination of cow’s milk proteins in early infancy on the subsequent risk of manifesting type 1 diabetes (Trial to Reduce IDDM in the Genetically at Risk, TRIGR) [17]. Thirty-eight of the 104 mothers (365%) had type 1 diabetes and the remaining 66 were unaffected. The mean age of the women at delivery was 315 56 (SD) years (range 190467 years) and the mean duration of diabetes in those with type 1 diabetes was 142 73 years (range 20280 years). The severity of maternal diabetes, classified according to White [18] was: 13 in class B, seven in class C, 12 in class D and six in class F. Mean individual HbA1c levels throughout pregnancy ranged from 46% to 79% (mean 64 08%), as compared with Eliglustat a reference range of 46% in nondiabetic subjects [19]. More than half of the newborn infants were girls (56/104; 538%). Mean gestational age was 391 17 weeks (range 351426 weeks), mean birth weight 3786 604 g (range 16955600) and mean length at birth 504 24 cm (range 410560 cm). Blood samples were.